메뉴 건너뛰기




Volumn 151, Issue 3, 2007, Pages 172-176

Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme;Pneumokokken- en hepatitis B-vaccinatie in het Rijksvaccinatieprogramma

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

EID: 33846606435     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (21)
  • 1
    • 33846615223 scopus 로고    scopus 로고
    • Algemene vaccinatie tegen meningokokken C en pneumokokken. Rapportnr 2001/27. Den Haag: Gezondheidsraad; 2001.
    • Algemene vaccinatie tegen meningokokken C en pneumokokken. Rapportnr 2001/27. Den Haag: Gezondheidsraad; 2001.
  • 2
    • 33846609359 scopus 로고    scopus 로고
    • Vaccinatie van zuigelingen tegen pneumokokkeninfecties. Rapportnr 2005/13. Den Haag: Gezondheidsraad; 2005.
    • Vaccinatie van zuigelingen tegen pneumokokkeninfecties. Rapportnr 2005/13. Den Haag: Gezondheidsraad; 2005.
  • 4
    • 33846627061 scopus 로고    scopus 로고
    • Oosten M van. Pneumokokkenvaccinatie in het Rijksvaccinatie-programma. Infectieziektenbulletin. 2006;11:137.
    • Oosten M van. Pneumokokkenvaccinatie in het Rijksvaccinatie-programma. Infectieziektenbulletin. 2006;11:137.
  • 5
    • 33846565590 scopus 로고    scopus 로고
    • Ploeg CPB van der, Amelink-Verburg MP. Draaiboek hepatitis B-immunisatie bij zuigelingen van hepatitis B-draagsters. TNO-rapport KvL/JPB 2005.142. Leiden: TNO; 2005.
    • Ploeg CPB van der, Amelink-Verburg MP. Draaiboek hepatitis B-immunisatie bij zuigelingen van hepatitis B-draagsters. TNO-rapport KvL/JPB 2005.142. Leiden: TNO; 2005.
  • 6
    • 4644354309 scopus 로고    scopus 로고
    • Hepatitis B vaccines
    • Hepatitis B vaccines. Wkly Epidemiol Rec. 2004;79:255-63.
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 255-263
  • 7
    • 0029846451 scopus 로고    scopus 로고
    • Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production
    • Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol. 1996;50:283-8.
    • (1996) J Med Virol , vol.50 , pp. 283-288
    • Zuckerman, J.N.1
  • 8
    • 13944279225 scopus 로고    scopus 로고
    • Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine
    • Tichmann-Schumann I, Soemantri P, Behre U, Disselhoff J, Mahler H, Maechler G, et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2005;24:70-7.
    • (2005) Pediatr Infect Dis J , vol.24 , pp. 70-77
    • Tichmann-Schumann, I.1    Soemantri, P.2    Behre, U.3    Disselhoff, J.4    Mahler, H.5    Maechler, G.6
  • 9
    • 32844475189 scopus 로고    scopus 로고
    • Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age
    • Scheifele DW, Halperin SA, Smith B, Ochnio J, Meloff K, Duarte-Monteiro D. Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. Vaccine. 2006;24:2057-64.
    • (2006) Vaccine , vol.24 , pp. 2057-2064
    • Scheifele, D.W.1    Halperin, S.A.2    Smith, B.3    Ochnio, J.4    Meloff, K.5    Duarte-Monteiro, D.6
  • 10
    • 33646835417 scopus 로고    scopus 로고
    • Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7 concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants
    • Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7 concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine. 2006;24:4727-36.
    • (2006) Vaccine , vol.24 , pp. 4727-4736
    • Knuf, M.1    Habermehl, P.2    Cimino, C.3    Petersen, G.4    Schmitt, H.J.5
  • 11
    • 27744548807 scopus 로고    scopus 로고
    • Prevention of perinatal transmission of hepatitis B to babies at high risk: An evaluation
    • Sloan D, Ramsay M, Prasad L, Gelb D, Teo CG. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine. 2005;23:5500-8.
    • (2005) Vaccine , vol.23 , pp. 5500-5508
    • Sloan, D.1    Ramsay, M.2    Prasad, L.3    Gelb, D.4    Teo, C.G.5
  • 12
    • 0028126666 scopus 로고
    • Review: Protective efficacy of hepatitis B vaccines in neonates
    • Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144-51.
    • (1994) J Med Virol , vol.44 , pp. 144-151
    • Andre, F.E.1    Zuckerman, A.J.2
  • 13
    • 33846620798 scopus 로고    scopus 로고
    • Vaccinatie van kinderen tegen hepatitis B. Rapportnr 2003/14. Den Haag: Gezondheidsraad; 2003.
    • Vaccinatie van kinderen tegen hepatitis B. Rapportnr 2003/14. Den Haag: Gezondheidsraad; 2003.
  • 14
    • 0030747213 scopus 로고    scopus 로고
    • Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity
    • Del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al. Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15:1624-30.
    • (1997) Vaccine , vol.15 , pp. 1624-1630
    • Del Canho, R.1    Grosheide, P.M.2    Mazel, J.A.3    Heijtink, R.A.4    Hop, W.C.5    Gerards, L.J.6
  • 15
    • 4544321809 scopus 로고    scopus 로고
    • Ploeg CPB van der, Kateman H, Vermeer-de Bondt PE, Verkerk PH. Verhoogd risico op hepatitis B door onvolledige of ontijdige immunisatie bij een kwart van de zuigelingen van hepatitis-B-virusdraagsters. Ned Tijdschr Geneeskd. 2004;148:1820-4.
    • Ploeg CPB van der, Kateman H, Vermeer-de Bondt PE, Verkerk PH. Verhoogd risico op hepatitis B door onvolledige of ontijdige immunisatie bij een kwart van de zuigelingen van hepatitis-B-virusdraagsters. Ned Tijdschr Geneeskd. 2004;148:1820-4.
  • 16
    • 4544348149 scopus 로고    scopus 로고
    • Bescherming van kinderen geboren uit met hepatitis-B-virus geïnfecteerde moeders
    • Boot HJ, Vermeer-de Bondt PE, Kimman TG. Bescherming van kinderen geboren uit met hepatitis-B-virus geïnfecteerde moeders. Ned Tijdschr Geneeskd. 2004;148:1816-8.
    • (2004) Ned Tijdschr Geneeskd , vol.148 , pp. 1816-1818
    • Boot, H.J.1    Vermeer-de Bondt, P.E.2    Kimman, T.G.3
  • 17
    • 33846564656 scopus 로고    scopus 로고
    • Standpunt 'Vaccinatie van kinderen tegen hepatitis B'. Tweede Kamer Der Staten-Generaal. Brief nr POG/ZP-2.460.495. Den Haag: Ministerie van VWS; 2004.
    • Standpunt 'Vaccinatie van kinderen tegen hepatitis B'. Tweede Kamer Der Staten-Generaal. Brief nr POG/ZP-2.460.495. Den Haag: Ministerie van VWS; 2004.
  • 18
    • 0038003144 scopus 로고    scopus 로고
    • Zonneveld M van, Nunen AB van, Niesters HG, Man RA de, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294-7.
    • Zonneveld M van, Nunen AB van, Niesters HG, Man RA de, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294-7.
  • 19
    • 33644638335 scopus 로고    scopus 로고
    • Aanpassing van het hepatitis B-vaccinatieschema voor zuigelingen van hepatitis B(HBsAg)-positieve moeders per 1 januari 2006
    • Geelen SPM. Aanpassing van het hepatitis B-vaccinatieschema voor zuigelingen van hepatitis B(HBsAg)-positieve moeders per 1 januari 2006. Ned Tijdschr Geneeskd. 2006;150:415-8.
    • (2006) Ned Tijdschr Geneeskd , vol.150 , pp. 415-418
    • Geelen, S.P.M.1
  • 20
    • 20144389088 scopus 로고    scopus 로고
    • Immunogenicity and safety of a combination pneumococcalmeningococcal vaccine in infants: A randomized controlled trial
    • Buttery JP, Riddell A, McVernon J, Chantler T, Lane L, Bowen-Morris J, et al. Immunogenicity and safety of a combination pneumococcalmeningococcal vaccine in infants: a randomized controlled trial. JAMA. 2005;293:1751-8.
    • (2005) JAMA , vol.293 , pp. 1751-1758
    • Buttery, J.P.1    Riddell, A.2    McVernon, J.3    Chantler, T.4    Lane, L.5    Bowen-Morris, J.6
  • 21
    • 0035658245 scopus 로고    scopus 로고
    • Haemophilus influenzae type b vaccine: Reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses
    • Vidor E, Hoffenbach A, Fletcher MA. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Curr Med Res Opin. 2001;17:197-209.
    • (2001) Curr Med Res Opin , vol.17 , pp. 197-209
    • Vidor, E.1    Hoffenbach, A.2    Fletcher, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.